A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
- PMID: 37859770
- PMCID: PMC10582981
- DOI: 10.3389/fped.2023.1244146
A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
Abstract
Allergic rhinoconjunctivitis (ARC) is a common disease that affects individuals of all ages. Pediatricians may be the first (and only) point of care for children with ARC. Sublingual immunotherapy (SLIT)-tablets are a convenient at-home, injection-free allergy immunotherapy option that can be used for the treatment of ARC. This paper provides a practical guide for pediatricians to aid in prescribing SLIT-tablets to children with ARC in North America. Topics include a summary of the available SLIT-tablets and their efficacy and safety, guidance on when SLIT-tablets are an appropriate option, and how to diagnose ARC and identify culprit allergens. Practical guidance is also provided through a proposed decision tree, a prescribing checklist and prescribing procedures, and suggested follow-up assessments.
Keywords: allergen immunotherapy; allergic rhinitis; checklist; children; decision tree; management; sublingual.
© 2023 Blaiss, DuBuske, Nolte, Opstrup and Rance.
Conflict of interest statement
MB has served as a consultant or speaker for ALK, Sanofi, Regeneron, Merck, Bellus, Hikma, Prollergy, and Lanier Biotherapeutics. LD has served as a consultant or speaker for ALK, Sanofi, Regeneron, Allergy Therapeutics, GSK, AstraZeneca, and Abionic. HN and MO are employees of ALK. KR was an employee of ALK when the work was conducted.
Figures

Similar articles
-
Efficacy and safety of sublingual allergen immunotherapy.Allergy Asthma Proc. 2022 Jul 1;43(4):272-280. doi: 10.2500/aap.2022.43.220036. Allergy Asthma Proc. 2022. PMID: 35818141 Clinical Trial.
-
Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets.Curr Ther Res Clin Exp. 2022 Jun 23;96:100678. doi: 10.1016/j.curtheres.2022.100678. eCollection 2022. Curr Ther Res Clin Exp. 2022. PMID: 35813554 Free PMC article.
-
The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.Allergol Int. 2018 Jul;67(3):301-308. doi: 10.1016/j.alit.2018.03.008. Epub 2018 May 16. Allergol Int. 2018. PMID: 29759659 Review.
-
Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.Clin Ther. 2018 Apr;40(4):574-586.e4. doi: 10.1016/j.clinthera.2018.02.012. Epub 2018 Mar 16. Clin Ther. 2018. PMID: 29551533 Clinical Trial.
-
Tablet-based sublingual immunotherapy for respiratory allergy.Allergol Immunopathol (Madr). 2017 Dec;45 Suppl 1:30-35. doi: 10.1016/j.aller.2017.09.008. Epub 2017 Nov 13. Allergol Immunopathol (Madr). 2017. PMID: 29146015 Review.
Cited by
-
Management of Allergic Rhinitis in the United Arab Emirates: Expert Consensus Recommendations on Allergen Immunotherapy.Cureus. 2024 Jul 24;16(7):e65260. doi: 10.7759/cureus.65260. eCollection 2024 Jul. Cureus. 2024. PMID: 39184659 Free PMC article.
-
Breaking the mold: nontraditional approaches to allergen immunotherapy for environmental allergens.Immunotherapy. 2024;16(18-19):1153-1169. doi: 10.1080/1750743X.2024.2408216. Epub 2024 Oct 9. Immunotherapy. 2024. PMID: 39382452 Review.
-
Degree of fear of needles and preferred allergy immunotherapy treatment among children with allergic rhinitis: caregiver survey results.Front Pediatr. 2024 Aug 2;12:1447619. doi: 10.3389/fped.2024.1447619. eCollection 2024. Front Pediatr. 2024. PMID: 39156023 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources